Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28

Journal of Experimental Medicine

Volumn 192, Issue 4, 2000, Pages 483-494

  Van Hall, Thorbald ^a   Sijts, Alice ^b   Camps, Marcel ^a   Offringa, Rienk ^a   Melief, Cornelis ^a   Kloetzel, Peter M ^b   Ossendorp, Ferry ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Antigen processing; Immunoproteasomes; Major histocompatibility complex class I; Murine leukemia virus; PA28

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; PROTEIN SUBUNIT; REGULATOR PROTEIN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION SYSTEM; GENE INDUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROCESSING;

ACETYLCYSTEINE; ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; AUTOANTIGENS; BLOTTING, WESTERN; CELL LINE; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON TYPE II; LEUKEMIA VIRUS, MURINE; MICE; MICE, INBRED C57BL; MULTIENZYME COMPLEXES; PRECIPITIN TESTS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; RATS; SULFONES; T-LYMPHOCYTES, CYTOTOXIC; TETRACYCLINE;

EID: 0034698738     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.192.4.483     Document Type: Article

References (42)

1. Mechanisms of MHC class I-restricted antigen processing
2. Degradation of cell protiens and the generation of MHC class I-presented peptides
3. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
4. Proteasomes and antigen processing
5. The MHC class I ligand-generating system: Roles of immunoproteasomes and the interferon-γ-inducible proteasome activator PA28
6. Interferon γ stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes
7. A third interferon-γ-induced subunit exchange in the 20S proteasome
8. Newly identified pair of proteasomal subunits regulated reciprocally by interferon γ
9. Identification of MECL-1 (LMP-10) as the third IFN-γ-inducible proteasome subunit
10. The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome
11. Incorporation of major histocompatibility complex-encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-γ
12. Altered peptidase and viral-specific T cell response in LMP2 mutant mice
13. MHC class I expression in mice lacking the proteasome subunit LMP-7
14. Identification, purification and characterization of a protein activator (PA28) of the 20S proteasome (macropain)
15. Purification of an 11 S regulator of the multicatalytic protease
16. Sequence and expression of mouse proteasome activator PA28 and the related autoantigen Ki
17. A model for the quarternary structure of the proteasome activator PA28
18. Relative functions of the α and β subunits of the proteasome activator, PA28
19. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands
20. A role for the proteasome regulator PA28α in antigen presentation
21. Impaired immunoproteasome assembly and immune responses in PA28(-/-) mice
22. Differential effect of transporter Tap2 gene introduction into RMA-S cells on viral antigen processing
23. b mutant bm13 mice
24. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors
25. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice
26. MHC class I antigen processing of an Adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells
27. Expression and subcellular localization of mouse 20S proteasome activator complex PA28
28. Cytotoxic T-cell response against lymphoblasts infected with moloney (Abelson) murine leukemia virus. Methodological aspects and H-2 requirements
29. Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site
30. Identification of a gag-encoded cytotoxic T lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney and Rauscher murine leukemia virus-induced tumors
31. Cytotoxic T lymphocytes against the antigen-processing-defective RMA-S tumor cell line
32. An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors
33. Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis
34. Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system
35. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation
36. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules
37. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences
38. The ubiquitin system
39. Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein
40. The proteasome inhibitor lactacystin prevents the generation of an endoplasmic reticulum leader-derived T cell epitope
41. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes
42. Simultaneous binding of PA28 and PA700 activators to 20S proteasomes